GC
SVA

Guggenheim Capital’s Sinovac Biotech, Ltd SVA Stock Holding History

Guggenheim Capital’s Portfolio SVA Stock Details SVA Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
2018
Q1 		$179K Sell
2017
Q4 		$173K Buy
2017
Q3 		$129K Buy
2017
Q2 		$123K Sell
2017
Q1 		$107K Sell
2016
Q4 		$126K Sell
2016
Q3 		$146K Buy
2016
Q2 		$147K Sell
2016
Q1 		$169K Sell
2015
Q4 		$167K Buy